Pipeline

Pipeline2020-08-25T21:51:09+00:00

ALTIBIO IS BUILDING ON PREVIOUS SUCCESS

ATB226 is the lead product candidate currently undergoing IND enabling activity. An IND is expected to be filed in 2021. Series B funding is being sought to carry the company through planned Phase 1 development.